---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-033360"
form_type: "8-K"
ticker: "ENSC"
cik: "0001716947"
company_name: "Ensysce Biosciences, Inc."
filed_at: "2026-07-15T20:15:43+00:00"
generated_at: "2026-07-15T20:17:05.332877+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Ensysce Biosciences COO Jeffrey Millard resigns effective July 10, 2026

## Summary
- Jeffrey Millard resigned as Chief Operating Officer on July 10, 2026.
- Resignation notice received and effective on the same date.
- No replacement or interim COO has been announced.

## SEC filing metadata
- accession: 0001493152-26-033360
- form_type: 8-K
- ticker: ENSC
- cik: 0001716947
- company_name: Ensysce Biosciences, Inc.
- filed_at: 2026-07-15T20:15:43+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716947/000149315226033360/0001493152-26-033360-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716947/000149315226033360/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-033360
- JSON: https://secwatch.observer/filing/0001493152-26-033360.json
- Plain text: https://secwatch.observer/filing/0001493152-26-033360.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.